Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about KKR Is In Talks To Sell This Drug Delivery Company For Over $5B
Venture Capital

KKR Is In Talks To Sell This Drug Delivery Company For Over $5B

by fortune.com posted 1year ago 831 views
Swiss pharmaceutical manufacturer Lonza Group on Monday confirmed it is in advanced talks with private equity firm KKR & Co to acquire Capsugel, a U.S. maker of capsule products and other drug delivery systems.